{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:18:26Z","timestamp":1762899506709,"version":"3.41.2"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>To investigate the relationship between histologic findings of the placenta and response to early postnatal hydrocortisone treatment used to prevent bronchopulmonary dysplasia (BPD) in extremely preterm infants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>In an exploratory analysis of the Early Low-Dose Hydrocortisone to Improve Survival Without Bronchopulmonary Dysplasia in Extremely Preterm Infants (PREMILOC) trial, detailed placental analyses were performed on the basis of standardized macroscopic and histologic examinations. Placental histology, categorized into 3 groups, was correlated to neonatal outcomes and response to hydrocortisone treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Of 523 randomly assigned patients, 457 placentas were analyzed. In total, 125 out of 457 (27%) placentas were classified as normal, 236 out of 457 (52%) placentas were classified as inflammatory, and 96 out of 457 (21%) placentas were classified as vascular. Placental inflammation was associated with a significant, increased rate of BPD-free survival at 36 weeks\u2019 postmenstrual age, independent of gestational age, treatment group, and sex (adjusted odds ratio: 1.72, 95% confidence interval [CI]: 1.05 to 2.82, P = .03). Regarding the response to treatment, the strongest benefit of hydrocortisone compared with placebo was found in infants born after placental vascular disease, with significantly more patients extubated at day 10 (risk difference: 0.32, 95% CI: 0.08 to 0.56, P = .004) and similar positive direction on survival without BPD (risk difference: 0.23, 95% CI: 0.00 to 0.46, P = .06). Adjusted to gestational age and treatment groups, placental inflammation was associated with significantly fewer patent ductus arteriosus ligation (adjusted hazard ratio: 0.58, 95% CI: 0.36 to 0.95, P = .03). Placental histology was not found to be associated with other adverse events related to preterm birth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>With these findings, we confirm that early low-dose hydrocortisone confers benefits in extremely preterm infants overall and we suggest there is a higher treatment effect in those born after placental vascular disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2017-1788","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T11:47:25Z","timestamp":1516621645000},"source":"Crossref","is-referenced-by-count":9,"title":["Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants"],"prefix":"10.1542","volume":"141","author":[{"given":"Alice","family":"H\u00e9neau","sequence":"first","affiliation":[{"name":"NICU,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Guimiot","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damir","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Unit of Clinical Epidemiology, Assistance Publique-H\u00f4pitaux de Paris, Centre Hospitalier Universitaire Robert Debr\u00e9 and University Paris Diderot, Sorbonne Paris-Cit\u00e9, Paris, France;"},{"name":"Inserm U1123 and Centre d'Investigation Clinique-\u00c9pid\u00e9miologie Clinique 1426, Paris, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Rideau Batista Novais","sequence":"additional","affiliation":[{"name":"NICU,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Alberti","sequence":"additional","affiliation":[{"name":"Unit of Clinical Epidemiology, Assistance Publique-H\u00f4pitaux de Paris, Centre Hospitalier Universitaire Robert Debr\u00e9 and University Paris Diderot, Sorbonne Paris-Cit\u00e9, Paris, France;"},{"name":"Inserm U1123 and Centre d'Investigation Clinique-\u00c9pid\u00e9miologie Clinique 1426, Paris, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Baud","sequence":"additional","affiliation":[{"name":"NICU,"},{"name":"Division of Neonatology and PICU, University Hospitals Geneva, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the PREMILOC Trial study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"2","key":"2021121100253108500_B1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00008480-200104000-00006","article-title":"Prevention of bronchopulmonary dysplasia.","volume":"13","author":"Jobe","year":"2001","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"2021121100253108500_B2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia.","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2021121100253108500_B3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0046-8177(98)90280-5","article-title":"Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.","volume":"29","author":"Husain","year":"1998","journal-title":"Hum Pathol"},{"issue":"4","key":"2021121100253108500_B4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000360842","article-title":"Fetal growth restriction is worse than extreme prematurity for the developing lung.","volume":"106","author":"Soud\u00e9e","year":"2014","journal-title":"Neonatology"},{"issue":"8","key":"2021121100253108500_B5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.placenta.2014.05.003","article-title":"Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension.","volume":"35","author":"Mestan","year":"2014","journal-title":"Placenta"},{"issue":"3","key":"2021121100253108500_B6","doi-asserted-by":"crossref","first-page":"e20152163","DOI":"10.1542\/peds.2015-2163","article-title":"Placental complications and bronchopulmonary dysplasia: EPIPAGE-2 cohort study.","volume":"137","author":"Torchin","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"2021121100253108500_B7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1542\/peds.107.2.413","article-title":"Postnatal glucocorticoids in very preterm infants: \u201cthe good, the bad, and the ugly\u201d?","volume":"107","author":"Th\u00e9baud","year":"2001","journal-title":"Pediatrics"},{"issue":"6","key":"2021121100253108500_B8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1542\/peds.104.6.1258","article-title":"Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.","volume":"104","author":"Watterberg","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"2021121100253108500_B9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2006.12.041","article-title":"Postnatal steroids for bronchopulmonary dysplasia: where are we now?","volume":"150","author":"Watterberg","year":"2007","journal-title":"J Pediatr"},{"issue":"10030","key":"2021121100253108500_B10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2021121100253108500_B11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10024-003-8083-2","article-title":"Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns.","volume":"7","author":"Redline","year":"2004","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"2021121100253108500_B12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.siny.2003.09.005","article-title":"Placental inflammation.","volume":"9","author":"Redline","year":"2004","journal-title":"Semin Neonatol"},{"issue":"1","key":"2021121100253108500_B13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.path.2012.11.006","article-title":"Monozygotic twinning.","volume":"6","author":"Benirschke","year":"2013","journal-title":"Surg Pathol Clin"},{"key":"2021121100253108500_B14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.placenta.2016.09.012","article-title":"The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome.","volume":"47","author":"Weiner","year":"2016","journal-title":"Placenta"},{"issue":"6","key":"2021121100253108500_B15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jp.7210963","article-title":"Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.","volume":"23","author":"Walsh","year":"2003","journal-title":"J Perinatol"},{"issue":"5","key":"2021121100253108500_B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM197802022980519","article-title":"Neonatal necrotizing enterocolitis.","volume":"298","author":"Bell","year":"1978","journal-title":"N Engl J Med"},{"issue":"suppl 4","key":"2021121100253108500_B17","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ajog.2015.08.040","article-title":"Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2021121100253108500_B18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3109\/14767058.2015.1053862","article-title":"Chorioamnionitis and neonatal outcome in preterm infants: a clinical overview.","volume":"29","author":"Pugni","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2021121100253108500_B19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1542\/peds.97.2.210","article-title":"Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.","volume":"97","author":"Watterberg","year":"1996","journal-title":"Pediatrics"},{"issue":"5","key":"2021121100253108500_B20","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1542\/peds.2008-0656","article-title":"Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study.","volume":"123","author":"Lahra","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2021121100253108500_B21","doi-asserted-by":"crossref","first-page":"F218","DOI":"10.1136\/adc.2008.150458","article-title":"Histological chorioamnionitis and respiratory outcome in preterm infants.","volume":"94","author":"Been","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021121100253108500_B22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jpeds.2011.09.025","article-title":"Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: a pregnancy disorder-based approach.","volume":"160","author":"Durrmeyer","year":"2012","journal-title":"J Pediatr"},{"issue":"1","key":"2021121100253108500_B23","first-page":"53","article-title":"That chorioamnionitis is a risk factor for bronchopulmonary dysplasia\u2013the case against.","volume":"15","author":"Lacaze-Masmonteil","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"2021121100253108500_B24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2017.05.019","article-title":"Histologic chorioamnionitis and bronchopulmonary dysplasia in preterm infants: the epidemiologic study on low gestational ages 2 cohort.","volume":"187","author":"Torchin","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"2021121100253108500_B25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/pr.2015.224","article-title":"Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats.","volume":"79","author":"Choi","year":"2016","journal-title":"Pediatr Res"},{"issue":"10","key":"2021121100253108500_B26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012.","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"2021121100253108500_B27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000092868","article-title":"Structural aspects of postnatal lung development\u2013alveolar formation and growth.","volume":"89","author":"Burri","year":"2006","journal-title":"Biol Neonate"},{"key":"2021121100253108500_B28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2431-4-9","article-title":"Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants.","volume":"4","author":"Sharma","year":"2004","journal-title":"BMC Pediatr"},{"issue":"4","key":"2021121100253108500_B29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1542\/peds.95.4.534","article-title":"The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?","volume":"95","author":"Tyson","year":"1995","journal-title":"Pediatrics"},{"issue":"3","key":"2021121100253108500_B30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/apa.12888","article-title":"Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia.","volume":"104","author":"Eriksson","year":"2015","journal-title":"Acta Paediatr"},{"issue":"12","key":"2021121100253108500_B31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/thx.2010.134742","article-title":"Patterns of fetal and infant growth are related to atopy and wheezing disorders at age 3 years.","volume":"65","author":"Pike","year":"2010","journal-title":"Thorax"},{"issue":"5","key":"2021121100253108500_B32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2010.05.002","article-title":"Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort.","volume":"157","author":"Zeitlin","year":"2010","journal-title":"J Pediatr"},{"issue":"6","key":"2021121100253108500_B33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1099-0496(199806)25:6<367::AID-PPUL2>3.0.CO;2-E","article-title":"Effects of intrauterine growth retardation and prematurity on spirometric flow values and lung volumes at school age in twin pairs.","volume":"25","author":"Nikolajev","year":"1998","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"2021121100253108500_B34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ppul.1109","article-title":"Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis.","volume":"32","author":"Maritz","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"2021121100253108500_B35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ppul.21532","article-title":"Effects of maternal food restriction on offspring lung extracellular matrix deposition and long term pulmonary function in an experimental rat model.","volume":"47","author":"Rehan","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2021121100253108500_B36","first-page":"1174","article-title":"Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses.","volume":"77","author":"Goland","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121100253108500_B37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1203\/PDR.0b013e318191fb44","article-title":"Blunted stress response in small for gestational age neonates.","volume":"65","author":"Sch\u00e4ffer","year":"2009","journal-title":"Pediatr Res"},{"issue":"3","key":"2021121100253108500_B38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/pr.2012.188","article-title":"Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation.","volume":"73","author":"Leviton","year":"2013","journal-title":"Pediatr Res"},{"issue":"3","key":"2021121100253108500_B39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1542\/peds.2011-1796","article-title":"Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns.","volume":"129","author":"Helderman","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"2021121100253108500_B40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuroscience.2008.10.032","article-title":"Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia\/ischemia: a novel animal model for cerebral palsy in very premature infants.","volume":"158","author":"Girard","year":"2009","journal-title":"Neuroscience"},{"issue":"12","key":"2021121100253108500_B41","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/glia.23079","article-title":"Transcriptomic regulations in oligodendroglial and microglial cells related to brain damage following fetal growth restriction.","volume":"64","author":"Rideau Batista Novais","year":"2016","journal-title":"Glia"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-1788\/918483\/peds_20171788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-1788\/918483\/peds_20171788.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T08:15:16Z","timestamp":1639210516000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/2\/e20171788\/38038\/Placental-Findings-and-Effect-of-Prophylactic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-1788","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"article-number":"e20171788"}}